菲利普莫里斯Q3盈利幻灯片为已发布财报的二次复述：EPS与营收双超预期，但全年营业利润指引偏区间下半部，无新增事实

Introduction & Market Context
Philip Morris International (NYSE:PM) presented its third-quarter 2026 results on October 21, 2026, highlighting what management characterized as an "excellent quarter" that delivered record profitability metrics even as the company significantly increased investments in its U.S. smoke-free business. Despite beating analyst expectations with adjusted earnings of $2.36 per share and revenue of $11.4 billion, the stock fell 2.01% to $195.88 in premarket trading, reflecting investor concerns about elevated spending levels and geopolitical cost pressures.
The presentation emphasized Philip Morris’s progress toward becoming a smoke-free company, with adjusted operating income surpassing $5 billion for the first time in a single quarter and operating margins approaching 45%. However, management acknowledged that full-year operating income growth may land in the lower half of its 7-9% guidance range due to ongoing geopolitical tensions and substantial growth investments in ZYN nicotine pouches.
Quarterly Performance Highlights
Philip Morris delivered strong top and bottom-line growth in the third quarter, demonstrating the resilience of both its smoke-free portfolio and traditional combustible business. As shown in the following table of key financial metrics, the company achieved organic growth across all major measures.
The company reported total shipment volume of 206 billion units in Q3 2026, up 0.6% organically versus the prior year. Net revenues reached $11.4 billion, growing 7.1% on an organic basis and 5.5% in reported terms. Adjusted gross profit of $7.9 billion represented 8.3% organic growth, while adjusted operating income climbed 10.5% organically to exceed $5 billion for the first time.
Adjusted diluted earnings per share of $2.36 grew 5.8% on a currency-neutral basis, marking a record quarterly level. The adjusted operating margin reached 44.7%, expanding by 130 basis points year-over-year as the company balanced productivity improvements with strategic growth investments.
For the nine months ended September 30, 2026, the performance trajectory remained equally strong, as illustrated in the following year-to-date comparison.
Year-to-date shipment volume totaled 596 billion units, up 0.5% organically. Net revenues of $32.8 billion grew 5.9% organically and 8.2% in reported terms, while adjusted operating income of $14.1 billion increased 7.7% organically. Year-to-date adjusted diluted EPS reached $6.52, up 8.4% excluding currency effects and 11.8% in reported terms.
Volume Growth and Product Mix
Philip Morris is on track for its sixth consecutive year of total volume growth, driven primarily by smoke-free product expansion. The following chart breaks down shipment volumes by category for both the quarter and year-to-date periods.
In Q3 2026, smoke-free product volumes reached 48.2 billion units, up 2.7% versus the prior year. Heated tobacco units grew 1.5%, oral smoke-free products increased 1.8%, and e-vapor surged 61.6%. Cigarette volumes of 158 billion units remained essentially flat year-over-year.
For the nine-month period, smoke-free products totaled 143.4 billion units, up 6.4%, while cigarette volumes declined 1.2% to 452.2 billion units. The shift in product mix toward higher-margin smoke-free alternatives contributed significantly to revenue and profit growth.
Revenue Growth Drivers
The company’s strong top-line performance reflected contributions from volume growth, pricing power, and favorable smoke-free product mix. The following waterfall chart illustrates how these factors combined to drive year-to-date organic net revenue growth.
Pricing across both combustibles and smoke-free products contributed 6.2 percentage points to year-to-date organic revenue growth of 5.9%. International smoke-free mix added 1.5 percentage points, while U.S. smoke-free mix reduced growth by 0.6 percentage points due to investment-related pricing actions. International combustible geographic mix and other factors detracted 1.7 percentage points.
For Q3 specifically, pricing contributed 6.8 percentage points to the 7.1% organic revenue growth, demonstrating the company’s continued ability to implement price increases across its portfolio.
Margin Expansion and Profitability
Despite significant growth investments, Philip Morris continued to expand operating margins through gross profit improvements and disciplined cost management. The following chart shows the progression of adjusted operating income margin.
Year-to-date adjusted operating income margin reached 42.9%, up 90 basis points from 42.0% in the prior-year period. Excluding currency and acquisition impacts, the margin improved 60 basis points to 42.6%, with gross profit contributing 80 basis points of expansion partially offset by a 20 basis point increase in SG&A as a percentage of sales.
For Q3 2026, the adjusted operating margin reached 44.7%, representing a 130 basis point improvement year-over-year. Management emphasized that margin expansion occurred even as the company reinvested for growth, particularly in the U.S. market.
International Business Performance
The international segment delivered excellent performance across both smoke-free and combustible categories. The following breakdown illustrates organic growth rates for key international metrics.
Total international net revenues grew 7.0% organically, while gross profit increased 9.1% and operating cash income rose 11.4%. The international smoke-free business posted 9.9% net revenue growth and 11.8% gross profit growth, with gross margin expanding 120 basis points to 70.0%. International combustibles achieved 5.2% net revenue growth and 7.4% gross profit growth, with margins up 140 basis points to 68.0%.
Strong international smoke-free product momentum is evident in the following in-market sales growth data.
International smoke-free product adjusted in-market sales grew 11.8% year-to-date, accelerating to 8.0% in Q3 2026. Excluding Japan and Poland, where tax changes created difficult comparisons, Q3 growth reached 10.8%. The company’s international smoke-free growth outpaced the industry by approximately one percentage point.
IQOS Heated Tobacco Performance
IQOS continued to demonstrate strong fundamentals and sustained growth momentum across global markets. The following chart shows heated tobacco unit adjusted in-market sales trends.
Heated tobacco unit adjusted in-market sales grew 10.8% year-to-date and 7.1% in Q3 2026. Excluding Japan and Poland, Q3 growth accelerated to 10.0%, reflecting strong underlying demand and effective commercial execution.
Philip Morris is making very good progress expanding IQOS presence in key global cities, as illustrated in the following market share data.
IQOS achieved significant offtake share gains across 20 major cities, with particularly strong performance in Rome (32.4% share, up 4.2 percentage points), Athens (33.7%, up 1.2 points), and Tokyo (38.5%, up 1.0 point). Emerging markets also showed promising growth, with Taipei reaching 8.3% share (up 8.3 points) and Amsterdam hitting 12.0% (up 3.3 points).
VEEV E-Vapor Expansion
VEEV delivered outstanding growth and established category leadership in European e-vapor markets. The following data illustrates shipment growth and market share trajectory.
VEEV e-vapor shipments reached 4.0 billion equivalent units year-to-date, representing 68% growth versus the prior year. In the European closed pods segment, VEEV’s market share reached 22.4% by mid-2026, surpassing a key competitor to establish leadership position. The brand maintained this share level through the second quarter, demonstrating sustainable competitive advantage.
ZYN Nicotine Pouch Performance
ZYN showed accelerating international growth momentum while the U.S. business absorbed significant investment. The following chart presents international modern oral shipment and in-market sales data.
International modern oral shipments totaled 1.5 billion pouches year-to-date, up 6.3% on a like-for-like basis and 25.1% excluding the Nordics. ZYN’s international in-market sales grew 30% year-to-date excluding Nordics, outpacing 27% industry growth in markets where the brand competes.
In the U.S. market, ZYN faced both opportunities and challenges as the company ramped up investment. The following performance data shows recent trends.
U.S. ZYN shipments reached 3.2 billion pouches in Q3 2026, up 4.2% versus the prior year and 13% excluding a September 2025 promotional comparison. Q3 organic net revenue growth accelerated to 22.7%, while gross profit grew 23.8% with gross margin expanding 60 basis points to 64.4%.
However, management indicated that U.S. profitability in Q4 2026 would be approximately break-even or slightly negative due to elevated marketing spending, portfolio expansion initiatives, and the transition to 20-pouch cans across the product line. These investments are expected to support ZYN’s substantial long-term growth potential from its leading premium brand position.
Combustible Business Resilience
The traditional combustible cigarette business continued to demonstrate remarkable pricing power and profit growth despite volume pressures. The following historical trends illustrate consistent performance improvement.
Combustible pricing growth reached 9.1% year-to-date 2026, accelerating from 7.6% in full-year 2025. International combustible gross profit grew 7.4% organically year-to-date, with Q3 growth reaching 9.8%. Marlboro maintained an 11.4% international market share in Q3 2026, underscoring the brand’s enduring strength.
2026 Outlook and Guidance
Philip Morris confirmed its full-year 2026 guidance while acknowledging headwinds from geopolitical cost pressures and U.S. growth investments. The following table presents the company’s outlook for key financial metrics.
Management maintained its expectation for 5-7% organic net revenue growth and 7-9% organic operating income growth, though operating income is now expected to land in the midpoint or lower half of the range due to cost impacts from ongoing geopolitical tensions and Ukraine-related disruptions.
The company kept its adjusted diluted EPS guidance at $8.29 to $8.44, representing 7.5% to 9.5% growth on a currency-neutral basis. At prevailing exchange rates, reported EPS growth is expected to reach approximately 10-12%. Operating cash flow is projected at around $13.5 billion, which would represent a record level.
Management emphasized that the outlook reflects excellent top-line performance partially offset by the cost impact of geopolitical tensions and previously announced U.S. growth investments. The company remains on track for another year of high-quality, best-in-class volume, sales, and profit growth, positioning it well for continued momentum into 2027 and beyond.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.